Comparison
NMN vs Astaxanthin
NMN
Nicotinamide mononucleotide — NAD+ precursor. Studied for cellular aging and metabolic health.
Astaxanthin
Red carotenoid pigment with high antioxidant potency. Crosses the blood-brain barrier and the blood-retinal barrier. Found in salmon, krill, and microalgae.
| Field | NMN | Astaxanthin |
|---|---|---|
| Category | neuroprotective | neuroprotective |
| Dose range | 250–1000mg | 4–12mg |
| Half-life | — | — |
| Onset | — | — |
| Evidence | EVIDENCEB | EVIDENCEB |
| Safety | ●●●●● | ●●●●● |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 600 | 2700 |
The comparison in plain English
Auto-generated from dataNMN and Astaxanthin are both in the neuroprotective category respectively. NMN Nicotinamide mononucleotide — NAD+ precursor. Astaxanthin Red carotenoid pigment with high antioxidant potency.
Bottom line
NMN (evidence B, safety 5/5) matches the evidence base of Astaxanthin (evidence B, safety 5/5). NMN has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose NMN if
NMN is the better fit when your goal aligns with its mechanism (Direct precursor to NAD+ — one biosynthetic step closer than nicotinamide riboside, bypassing the NRK1/NRK2 enzymatic step) and the dose range (250–1000mg) suits your protocol. Half-life is —h.
Choose Astaxanthin if
Astaxanthin is the better fit when your goal aligns with its mechanism (A red carotenoid with antioxidant capacity approximately 500-1000x stronger than vitamin E and 10x stronger than beta-carotene by some measures) and the dose range (4–12mg) suits your protocol. Half-life is —h.